glp-1 leefar Drink Mix – Dual-Action Craving Metabolism Support | Berberine, Chromium, 5-HTP, Yerba Mate Magnesium | Supports GLP-1 Pathway, Blood Sugar Gut Health Prescription GLP-1s for Weight Loss

Found Health's 2026 program details reflect increasing consumer demand for transparency in telehealth weight loss programs, particularly around insurance coverage, medication pathways, and total program cost

Ethics declarations Competing interests All authors, with the exception of D.J.D

Journal of Crohns and Colitis

Access and Convenience Differences Traditional in-person care: Requires scheduling appointments during office hours Travel time to and from appointments Waiting room time Face-to-face interaction with providers Physical examination capability Immediate emergency intervention if needed during visits Zealthy telehealth care: Asynchronous messaging (respond when convenient) No travel or waiting room time Video or phone visits available for more complex discussions 24/7 message submission (responses typically within 48 hours on business days) Limited physical examination capability Emergency situations require you to seek local care independently Oversight and Coordination Differences Traditional in-person care: Provider likely has access to your complete medical record Can coordinate with your other healthcare providers more easily Physical examination at each visit In-person vital sign monitoring (blood pressure, heart rate) Ability to order labs and review results in integrated systems Zealthy telehealth care: Limited to information you provide through intake forms and messaging You're responsible for coordinating between Zealthy providers and your primary care team No physical examination capability You may need to arrange separate lab work if recommended Relies on self-reported data for monitoring Neither approach is inherently "better"-they serve different needs

Comprehensive ePRO Portfolio: We have experience in supporting a wide range of ePRO measures to assess aspects of health important to patients with these diseases including: Health-related quality of life (HRQoL, e.g., SF-36, Impact of Weight on Quality of Life-Lite (IWQoL-Lite)(EQ-5D-5L), Food craving (e.g., Control of Eating Questionnaire (CoEQ)), Mental health (e.g., Columbia-Suicide Severity Rating Scale (C-SSRS), Patient Health Questionnaire-9 (PHQ-9)) and other measures such as the Patient Global Impression of Severity/Change (PCIS/C)

"Our goal is to provide personalized and AI-based nutrition-first care for the top food-related illnessesObesity, Type 2 diabetes, gastrointestinal disorders, and mental health," said Ranjan Sinha, Founder and CEO at Digbi Health